Prostate-specific antigen in serum during the menstrual cycle

Clinical Chemistry

Volumn 43, Issue 10, 1997, Pages 1862-1867

  Zarghami, Nosratollah ^a,b   Grass, Linda ^a   Sauter, Edward R ^c   Diamandis, Eleftherios P ^a,b,d  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c FOX CHASE CANCER CENTER   (United States)

^d Pediatric Oral and Maxillofacial Surgery   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MESSENGER RNA; PROGESTERONE; PROLACTIN; PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; FEMALE; FOLLICULAR PHASE; HUMAN; HUMAN CELL; MENSTRUAL CYCLE; NORMAL HUMAN; PROGESTERONE BLOOD LEVEL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS REGULATION;

EID: 0030882174     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/43.10.1862     Document Type: Article

References (23)

1. McLachlan RI, Robertson DM, Healy DL, Burger HG, de Kretser DM. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab 1987;65:954-61.
2. Strauss JF III, Steinkampf MP. Pituitary-ovarian interactions during follicular maturation and ovulation. Am J Obstet Gynecol 1995;172:726-35.
3. Erikson GF, Danforth DR. Ovarian control of follicle development. Am J Obstet Gynecol 1995;172:736-47.
4. Qu J, Thomas K. Inhibin and activin production in human placenta. Endocr Rev 1995;16:485-507.
5. Luke MC, Coffey DS. Human androgen receptor binding to the androgen response element of prostate specific antigen. J Androl 1994;15:41-51.
6. Diamandis EP, Yu H. New biological function of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
7. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate specific antigen in female breast. J Biol Chem 1995;270:6615-8.
8. Yu H, Giai M, Diamandis EP, Katsaros D, Sutherland DJA, Levesque MA, et al. Prostate specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104-10.
9. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.
10. Yu H, Diamandis EP. Prostate-specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41:204-10.
11. Yu H, Diamandis EP, Zarghami N, Grass L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994;32:291-300.
12. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate specific antigen gene expression in breast cancer. Br J Cancer 1997;75:579-88.
13. Glover JF, Darbre FD. Multihormone regulation of MMTV-LTR in transfected T-47D human breast cancers. J Steroid Biochem 1989;32:357-63.
14. Nordeen SK, Kuhnel B, Lawler-Heavner J, Barber DA, Edwards DP. A quantitative comparison of dual control of hormone response element by progestins and glucocorticoids in the same cell line. Mol Endocrinol 1989;3:1270-8.
15. Berthois Y, Katzenellenbogen JA, Katzenellenbogen BS. Phenol red in tissue culture medium is a weak estrogen: implications concerning the study of estrogen responsive cells in culture. Proc Natl Acad Sci U S A 1986;83:2496-500.
16. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate specific antigen by time-resolved immunofluorometric assay and the Immulite® immunochemiluminescent third-generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675-84.
17. Deguchi T, Dio T, Ehara H, Ito S, Takahashi Y, Nishino Y, et al. Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction. Cancer Res 1993;53:5350-4.
18. Okazaki T. Detection of estrogen receptor (ER) mRNA by use of reverse transcriptase-polymerase chain reaction (RT-PCR) assay; comparison with dextran coated charcoal (DCC) assay and immunocytochemical assay. Jpn J Cancer Chemother 1992;19:361-6.
19. Clements J, Mukhtar A. Glandular kallikreins and prostate specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994;78:1536-9.
20. Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 1995;153: 1004-8.
21. Diamandis EP, Yu H, Melegos DN. Ultrasensitive prostate-specific antigen assays and their clinical application. Clin Chem 1996;42: 853-7.
22. Lilja H. A kallikrein-like serine protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985;76: 1899-903.
23. Clements J, Yap B, Mukhtar A, Ehrlich A, Salamonsen L. Prostate-specific antigen and glandular kallikrein expression in the human endometrium across the menstrual cycle [Abstract P3-344]. Proc Int Congress Endocrinol 1996:840.